$DOMH
Dominari Holdings Inc. Stock $domh

$domh Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024041336 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$6.174M	$1.367M	$0.00
YoY Change	8595.77%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$8.910M	$4.172M	$3.833M
YoY Change	-1.87%	8.84%	114.49%
% of Gross Profit
Research & Development			$0.00
YoY Change			-100.0%
% of Gross Profit
Depreciation & Amortization	$26.00K	$26.00K	$7.000K
YoY Change	30.0%	271.43%
% of Gross Profit
Operating Expenses	$8.910M	$4.172M	$3.834M
YoY Change	-1.89%	8.82%	0.82%
Operating Profit	-$2.736M	-$2.805M	-$3.834M
YoY Change	-69.64%	-26.84%	0.82%
Interest Expense	-$2.642M	-$1.721M	$70.00K
YoY Change	-571.79%	-2558.57%	-65.69%
% of Operating Profit
Other Income/Expense, Net	-$3.384M	-$2.636M	$72.00K
YoY Change	-1072.41%	-3761.11%	12.5%
Pretax Income	-$6.120M	-$5.441M	-$3.760M
YoY Change	-29.33%	44.71%	6.36%
Income Tax
% Of Pretax Income
Net Earnings	-$6.120M	-$5.441M	-$3.762M
YoY Change	-29.35%	44.63%	6.42%
Net Earnings / Revenue	-99.13%	-398.02%
Basic Earnings Per Share	-$1.01	-$0.91	-$0.71
Diluted Earnings Per Share	-$1.01	-$0.91	-$0.71
COMMON SHARES
Basic Shares Outstanding	5.935M shares	5.935M shares	4.841M shares
Diluted Shares Outstanding	6.063M shares	5.995M shares	5.306M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.12M	$7.079M	$33.93M
YoY Change	-50.06%	-79.13%	-50.52%
Cash & Equivalents	$5.802M	$1.956M	$9.533M
Short-Term Investments	$6.320M	$5.123M	$24.39M
Other Short-Term Assets	$15.68M	$16.32M	$4.300M
YoY Change	101.01%	279.63%	-79.81%
Inventory
Prepaid Expenses
Receivables	$964.0K	$1.955M	$6.500M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$28.77M	$25.36M	$44.77M
YoY Change	-25.13%	-43.36%	-54.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$291.0K	$317.0K	$353.0K
YoY Change	-24.81%	-10.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$15.29M	$21.69M	$23.10M
YoY Change	-34.12%	-6.1%	24.13%
Other Assets	$458.0K	$458.0K	$500.0K
YoY Change	-8.4%	-8.4%	222.58%
Total Long-Term Assets	$20.31M	$26.84M	$29.38M
YoY Change	-30.63%	-8.67%	56.58%
TOTAL ASSETS
Total Short-Term Assets	$28.77M	$25.36M	$44.77M
Total Long-Term Assets	$20.31M	$26.84M	$29.38M
Total Assets	$49.07M	$52.19M	$74.15M
YoY Change	-27.51%	-29.61%	-37.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$944.0K	$840.0K	$600.0K
YoY Change	372.0%	40.0%	187.08%
Accrued Expenses	$2.499M	$714.0K	$1.000M
YoY Change	149.9%	-28.6%	45.77%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.899M	$1.596M	$1.720M
YoY Change	46.69%	-7.21%	92.18%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.815M	$2.929M	$3.400M
YoY Change	-14.7%	-13.85%
Total Long-Term Liabilities	$2.815M	$2.929M	$3.400M
YoY Change	-14.7%	-13.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.899M	$1.596M	$1.720M
Total Long-Term Liabilities	$2.815M	$2.929M	$3.400M
Total Liabilities	$6.714M	$4.525M	$5.083M
YoY Change	13.47%	-10.98%	467.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$220.3M	-$214.2M	-$189.6M
YoY Change	11.1%	12.95%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$501.0K	$501.0K	$501.0K
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$42.36M	$47.67M	$69.07M
YoY Change
Total Liabilities & Shareholders Equity	$49.07M	$52.19M	$74.15M
YoY Change	-27.51%	-29.61%	-37.13%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$6.120M	-$5.441M	-$3.762M
YoY Change	-29.35%	44.63%	6.42%
Depreciation, Depletion And Amortization	$26.00K	$26.00K	$7.000K
YoY Change	30.0%	271.43%
Cash From Operating Activities	$1.409M	-$8.594M	-$3.991M
YoY Change	-114.2%	115.33%	4.04%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		$360.0K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$2.437M	$7.717M	-$18.35M
YoY Change	-39.68%	-142.05%	82.08%
Cash From Investing Activities	$2.437M	$7.717M	-$18.71M
YoY Change	-38.92%	-141.24%	85.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000		-$939.0K
YoY Change			-104.94%
NET CHANGE
Cash From Operating Activities	1.409M	-$8.594M	-$3.991M
Cash From Investing Activities	2.437M	$7.717M	-$18.71M
Cash From Financing Activities	0.000		-$939.0K
Net Change In Cash	3.846M	-$877.0K	-$23.64M
YoY Change	-164.86%	-96.29%	-565.65%
FREE CASH FLOW
Cash From Operating Activities	$1.409M	-$8.594M	-$3.991M
Capital Expenditures	$0.00		$360.0K
Free Cash Flow	$1.409M	-$8.594M	-$4.351M
YoY Change	-114.12%	97.52%	13.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41845
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	DOMINARI HOLDINGS INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-0849320
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	725 5th Avenue
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	22nd Floor
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2024Q1	dei	City Area Code CityAreaCode	(212)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	393-4540
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock ($0.0001 par value per share)
CY2024Q1	dei	Trading Symbol TradingSymbol	DOMH
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5934917	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1956000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2833000	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5123000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	13547000	usd
CY2024Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	14094000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	7687000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2230000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	898000	usd
CY2024Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1955000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	3177000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	25358000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	28142000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	317000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	344000	usd
CY2024Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1128000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1129000	usd
CY2024Q1	us-gaap	Long Term Investments LongTermInvestments	21691000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	24150000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3242000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3335000	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	458000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	458000	usd
CY2024Q1	us-gaap	Assets Assets	52194000	usd
CY2023Q4	us-gaap	Assets Assets	57558000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	840000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1036000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	51000	usd
CY2024Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	295000	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	77000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	419000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	421000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	42000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	22000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1596000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1607000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2929000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3028000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	4525000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4635000	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5995065	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5995065	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5934917	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5934917	shares
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	262374000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	262187000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	60148	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	60148	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	501000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	501000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-214204000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-208763000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	47669000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	52923000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52194000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57558000	usd
CY2024Q1	us-gaap	Revenues Revenues	1367000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4172000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3834000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	4172000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3834000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2805000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3834000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	164000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	137000	usd
CY2024Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	574000	usd
CY2023Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-65000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	-915000	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2459000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2636000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	72000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-5441000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3762000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.71
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5995065	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5305513	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	52923000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	187000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-5441000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	47669000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73767000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	5000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	939000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3762000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	69071000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-5441000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3762000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	93000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	92000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	26000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	7000	usd
CY2024Q1	domh	Change In Fair Value Of Longterm Investment ChangeInFairValueOfLongtermInvestment	2459000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	187000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5000	usd
CY2024Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-93000	usd
CY2023Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-56000	usd
CY2024Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	473000	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-130000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	-915000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	221000	usd
CY2023Q1	domh	Increase Decrease In Prepaid Acquisition Cost IncreaseDecreaseInPrepaidAcquisitionCost	-301000	usd
CY2024Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	6407000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-196000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-19000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-51000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-528000	usd
CY2024Q1	domh	Increase Decrease In Accrued Commissions IncreaseDecreaseInAccruedCommissions	218000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-101000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	7000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	20000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	3000	usd
CY2024Q1	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	-58000	usd
CY2023Q1	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	62000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8594000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3991000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	24000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	17519000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	8829000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	68000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	361000	usd
CY2023Q1	domh	Acquisition Of Fps Net Of Cash Acquired And Receivable Owed From Fps AcquisitionOfFPSNetOfCashAcquiredAndReceivableOwedFromFPS	1149000	usd
CY2024Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	250000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	250000	usd
CY2024Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	1340000	usd
CY2024Q1	domh	Proceedsfrom Collectionof Loans To Employees ProceedsfromCollectionofLoansToEmployees	2000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7717000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18711000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	939000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-939000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-877000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-23641000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2833000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33174000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1956000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9533000	usd
CY2022Q4	domh	Investments Company Fee Paid Indirectly InvestmentsCompanyFeePaidIndirectly	2000000	usd
CY2024Q1	us-gaap	Investment Company Fee Paid Indirectly InvestmentCompanyFeePaidIndirectly	1400000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include stock-based compensation, the valuation of investments, the valuation of notes receivable and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</p>
CY2024Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	14100000	usd
CY2024Q1	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-93000	usd
CY2023Q1	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-56000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	473000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-130000	usd
CY2024Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	193000	usd
CY2023Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	121000	usd
CY2024Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	574000	usd
CY2023Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-65000	usd
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	20922000	usd
CY2024Q1	us-gaap	Long Term Investments LongTermInvestments	21691000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	24150000	usd
CY2024Q1	domh	Public Offering Price PublicOfferingPrice	4
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	63000000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	5123000	usd
CY2024Q1	us-gaap	Marketable Securities MarketableSecurities	5123000	usd
CY2024Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1955000	usd
CY2023Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	1128000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	13547000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	13547000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	3177000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1129000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P7Y
CY2023Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	12874000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	13502000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P7Y
CY2022Q3	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	49368000	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	51868000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3242000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	419000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2929000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3348000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1160000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4541000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1193000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3348000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y2M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M12D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q1	us-gaap	Lease Cost LeaseCost	200000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	200000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	178000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	134000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	178000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	134000	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	22000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	30000	usd
CY2024Q1	domh	Operating Lease Rent Expense Net OperatingLeaseRentExpenseNet	200000	usd
CY2023Q1	domh	Operating Lease Rent Expense Net OperatingLeaseRentExpenseNet	164000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	187000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	34000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2796000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P5Y
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	560000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	685000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	685000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	685000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	766000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1001235	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	476023	shares
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	60148	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	136309	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.26
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	136309	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.26
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	200000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	420168	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.8
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M18D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	72	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6410.74
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	420096	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.71
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	108666	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	8.37
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P8Y7M6D
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	100000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5000000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	400000	usd
CY2024Q1	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	409000	usd
CY2024Q1	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	310000	usd
CY2024Q1	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts	341000	usd
CY2024Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	307000	usd
CY2024Q1	us-gaap	Revenues Revenues	1367000	usd
CY2024Q1	us-gaap	Excess Capital ExcessCapital	13300000	usd
CY2024Q1	us-gaap	Capital Units Net Amount CapitalUnitsNetAmount	100000	usd
CY2024Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	usd
CY2023Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	80000000	usd
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q1	us-gaap	Revenues Revenues		usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable		usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.71
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5305513	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5995065	shares
CY2023Q1	domh	Stock Issued During Period Value Cancellation Of Common Stock StockIssuedDuringPeriodValueCancellationOfCommonStock		usd
CY2023Q1	us-gaap	Treasury Stock Retired Par Value Method Amount TreasuryStockRetiredParValueMethodAmount		usd
CY2023Q1	domh	Change In Fair Value Of Longterm Investment ChangeInFairValueOfLongtermInvestment		usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable		usd
CY2024Q1	domh	Increase Decrease In Prepaid Acquisition Cost IncreaseDecreaseInPrepaidAcquisitionCost		usd
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2023Q1	domh	Increase Decrease In Accrued Commissions IncreaseDecreaseInAccruedCommissions		usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2024Q1	domh	Acquisition Of Fps Net Of Cash Acquired And Receivable Owed From Fps AcquisitionOfFPSNetOfCashAcquiredAndReceivableOwedFromFPS		usd
CY2023Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable		usd
CY2023Q1	domh	Proceedsfrom Collectionof Loans To Employees ProceedsfromCollectionofLoansToEmployees		usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2024Q1	domh	Employee Options Expired Weighted Average Remaining Contractual Life EmployeeOptionsExpiredWeightedAverageRemainingContractualLife
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2023Q1	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss		usd
CY2023Q1	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue		usd
CY2023Q1	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts		usd
CY2023Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther		usd
CY2023Q1	us-gaap	Revenues Revenues		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000012239

Files In Submission

Name	View Source	Status
0001213900-24-041336-index-headers.html	Edgar Link	pending
0001213900-24-041336-index.html	Edgar Link	pending
0001213900-24-041336.txt	Edgar Link	pending
0001213900-24-041336-xbrl.zip	Edgar Link	pending
domh-20240331.xsd	Edgar Link	pending
ea0205166-10q_dominari.htm	Edgar Link	pending
ea020516601ex31-1_dominari.htm	Edgar Link	pending
ea020516601ex31-2_dominari.htm	Edgar Link	pending
ea020516601ex32-1_dominari.htm	Edgar Link	pending
ea020516601ex32-2_dominari.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
domh-20240331_cal.xml	Edgar Link	unprocessable
domh-20240331_def.xml	Edgar Link	unprocessable
domh-20240331_lab.xml	Edgar Link	unprocessable
domh-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0205166-10q_dominari_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DOMH
Dominari Holdings Inc. Stock $domh

2024 Q2 Form 10-Q Financial Statement

#000121390024041336 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOMH Dominari Holdings Inc. Stock $domh

2024 Q2 Form 10-Q Financial Statement

#000121390024041336 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOMH
Dominari Holdings Inc. Stock $domh